Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer
Background/Aims: Androgen receptor (AR), a steroid hormone receptor, has recently emerged as prognostic and treatment-predictive marker in breast cancer. Previous studies have shown that AR is widely expressed in up to one-third of triple-negative breast cancer (TNBC). However, the role of AR in TNB...
Main Authors: | Aiyu Zhu, Yan Li, Wei Song, Yumei Xu, Fang Yang, Wenwen Zhang, Yongmei Yin, Xiaoxiang Guan |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2016-03-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/443052 |
Similar Items
-
Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
by: Maša Brumec, et al.
Published: (2021-04-01) -
Régulation épigénétique et protéique de p73 dans le Myélome Multiple
by: Gillardin, Pierre
Published: (2017) -
The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer
by: Yan Shen, et al.
Published: (2017-10-01) -
Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
by: Mirco Pistelli, et al.
Published: (2014-06-01) -
Androgen Receptor Expression in Triple-Negative Breast Cancer
by: Samane Jam, et al.
Published: (2019-05-01)